Healthcare provider profile · identity verified

Henry Lucius Laffitte, MD

Family Practice · BEAUFORT, SC · NPI 1912998204

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	419	126
Amlodipine Besylate	Amlodipine Besylate	401	102
Atorvastatin Calcium	Atorvastatin Calcium	307	91
Losartan Potassium	Losartan Potassium	238	62
Levothyroxine Sodium	Levothyroxine Sodium	182	52
Eliquis	Apixaban	143	31
Omeprazole	Omeprazole	143	42
Metoprolol Succinate	Metoprolol Succinate	141	41
Metformin Hcl	Metformin Hcl	140	40
Simvastatin	Simvastatin	137	38
Hydrochlorothiazide	Hydrochlorothiazide	132	34
Escitalopram Oxalate	Escitalopram Oxalate	128	31
Tamsulosin Hcl	Tamsulosin Hcl	116	38
Zolpidem Tartrate	Zolpidem Tartrate	113	41
Lisinopril	Lisinopril	112	33
Azithromycin	Azithromycin	110	98
Albuterol Sulfate Hfa	Albuterol Sulfate	104	62
Ezetimibe	Ezetimibe	99	29
Prednisone	Prednisone	92	73
Meloxicam	Meloxicam	85	30
Montelukast Sodium	Montelukast Sodium	85	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	69	15
Pravastatin Sodium	Pravastatin Sodium	69	20
Celecoxib	Celecoxib	68	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	67	57
Gabapentin	Gabapentin	66	22
Famotidine	Famotidine	65	19
Ozempic	Semaglutide	63	suppressed
Duloxetine Hcl	Duloxetine Hcl	60	20
Olmesartan Medoxomil	Olmesartan Medoxomil	59	16
Trazodone Hcl	Trazodone Hcl	59	17
Pantoprazole Sodium	Pantoprazole Sodium	57	24
Allopurinol	Allopurinol	54	18
Lorazepam	Lorazepam	54	24
Mounjaro	Tirzepatide	54	suppressed
Carvedilol	Carvedilol	46	suppressed
Valacyclovir	Valacyclovir Hcl	46	24
Atenolol	Atenolol	45	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	44	39
Doxycycline Hyclate	Doxycycline Hyclate	44	29
Fluticasone Propionate	Fluticasone Propionate	44	26
Furosemide	Furosemide	43	21
Esomeprazole Magnesium	Esomeprazole Magnesium	42	suppressed
Mirtazapine	Mirtazapine	41	11
Synthroid	Levothyroxine Sodium	39	suppressed
Methylprednisolone	Methylprednisolone	38	32
Sertraline Hcl	Sertraline Hcl	38	11
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	37	37
Alprazolam	Alprazolam	35	11
Donepezil Hcl	Donepezil Hcl	35	suppressed
Finasteride	Finasteride	35	suppressed
Potassium Chloride	Potassium Chloride	35	12
Dutasteride	Dutasteride	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Tramadol Hcl	Tramadol Hcl	31	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	30	suppressed
Cefdinir	Cefdinir	29	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	17
Eszopiclone	Eszopiclone	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Spironolactone	Spironolactone	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Mupirocin	Mupirocin	26	24
Estradiol	Estradiol	25	suppressed
Azelastine Hcl	Azelastine Hcl	24	13
Colesevelam Hcl	Colesevelam Hcl	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Irbesartan	Irbesartan	23	suppressed
Valsartan	Valsartan	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Clonazepam	Clonazepam	22	suppressed
Premarin	Estrogens, Conjugated	22	suppressed
Zaleplon	Zaleplon	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Ondansetron Odt	Ondansetron	20	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Diazepam	Diazepam	19	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Amoxicillin	Amoxicillin	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	15
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	16
Pregabalin	Pregabalin	17	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Icosapent Ethyl	Icosapent Ethyl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Cephalexin	Cephalexin	15	12
Fluconazole	Fluconazole	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	11
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error